Active Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The Department of Health and Human Services is seeking pharmaceutical products for CDER research studies through an IDIQ contract. The previous contract had a ceiling of $9.5 million, and the period of performance for the incumbent contract is from September 30, 2020, to September 29, 2025. Interested parties should refer to the attached combined synopsis/solicitation for details.
5/11/2026: Questions and answers: Current or most recent incumbent contractor/vendor name Response: WE Pharma, LLC Previous contract number and/or SAM.gov solicitation number Response: Previous contract number 75F40120D00032 and solicitation number FDASOL1222072. Contract award value or estimated annual spend Response: The prior IDIQ Ceiling was $9,500,000.00. Historical pricing information or awarded pricing structure Response: Historical pricing information and awarded pricing structure are not being provided as part of this solicitation Q&A. Requests for agency records on pricing may be submitted through the applicable FOIA process and will be reviewed for releasability. Period of performance of the incumbent contract Response: 9/30/2020 to 9/29/2025. Any publicly available award documentation or reference links Response: None that we are aware of. 5/4/2026: See attached amendment 1 which updates the SBCX link for the subcontracting plan. See attached combined synopsis/solicitation.
Pharmaceutical Products for CDER Research Studies - IDIQ is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.